CT Financial Advisors’s AbbVie ABBV Stock Holding History

CT Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$679K	Sell	10,423 -68	-0.6%	-$4.28K	0.42%	63
2016 Q4	$657K	Buy	10,491 +25	+0.2%	+$1.53K	0.42%	63
2016 Q3	$660K	Sell	10,466 -265	-2%	-$17.2K	0.4%	64
2016 Q2	$664K	Sell	10,731 -53	-0.5%	-$3.23K	0.41%	62
2016 Q1	$616K	Sell	10,784 -385	-3%	-$21.5K	0.35%	73
2015 Q4	$662K	Buy	11,169 +1,011	+10%	+$58.2K	0.38%	68
2015 Q3	$553K	Sell	10,158 -187	-2%	-$12.2K	0.35%	74
2015 Q2	$695K	Sell	10,345 -229	-2%	-$14.9K	0.39%	67
2015 Q1	$619K	Buy	10,574 +11	+0.1%	+$665	0.34%	77
2014 Q4	$691K	Buy	+10,563	New	+$666K	0.52%	49
2014 Q1	$619K	Buy	+10,574	New	+$534K	0.34%	77

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

CT Financial Advisors's ABBV Position: Q1 2017 in Review

CT Financial Advisors reduced its AbbVie (ABBV) stake by 0.65% in Q1 2017, selling an estimated $4.28K and leaving 10,423 shares worth $679K. The position accounts for 0.42% of the portfolio, ranked #63.

CT Financial Advisors first reported a position in ABBV in Q1 2014 and has held it in 11 quarters since. The position peaked at $695K in Q2 2015. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

CT Financial Advisors held 10,423 shares of AbbVie worth $679K as of Q1 2017.
CT Financial Advisors sold 68 AbbVie shares in Q1 2017, an estimated $4.28K.
AbbVie made up 0.42% of CT Financial Advisors's portfolio in Q1 2017, its #63 holding.
CT Financial Advisors first reported a position in AbbVie in Q1 2014 and has held it in 11 quarters since.
CT Financial Advisors's AbbVie position peaked at $695K in Q2 2015.
1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.